Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.3 to v3.5.4, signaling a standard site version update. No visible changes to the study details or page functionality were observed.
    Difference
    0.1%
    Check dated 2026-05-17T10:30:50.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s revision/build identifier was updated from v3.5.2 to v3.5.3, reflecting a minor website release without changing the displayed study record.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:35.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:30:13.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T00:56:04.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:46:01.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    A minor revision tag was updated from v3.4.1 to v3.4.2, with no substantive changes to study content or page elements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T20:44:34.000Z thumbnail image

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.